相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: A population-based study
Tanja Eder et al.
EUROPEAN JOURNAL OF CANCER (2007)
Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk
A. Nieters et al.
GENES AND IMMUNITY (2006)
Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review
S. P. Balasubramanian et al.
BMC CANCER (2006)
SNP-SNP interactions in breast cancer susceptibility
Venus Ummiye Onay et al.
BMC CANCER (2006)
Correlation of interieukin-10 gene haplotype with hepatocellular carcinoma in Taiwan
LH Tseng et al.
TISSUE ANTIGENS (2006)
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells
M Todaro et al.
CANCER RESEARCH (2006)
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
N Rothman et al.
LANCET ONCOLOGY (2006)
Interleukin-10 polymorphisms, cancer susceptibility and prognosis
W. Martin Howell et al.
FAMILIAL CANCER (2006)
Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type
C Pratesi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer
CM Shih et al.
LUNG CANCER (2005)
Molecular classification and biomarker discovery in papillary thyroid carcinoma
O Sheils
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2005)
Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to γ-radiation:: A model of carcinogenic chromosomal rearrangement induced by ionizing radiation
CM Caudill et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk
U Langsenlehner et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma
E Havranek et al.
JOURNAL OF UROLOGY (2005)
TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer
C Seifart et al.
DISEASE MARKERS (2005)
IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma
G Mazur et al.
IMMUNOLOGY LETTERS (2005)
Ret/PTC activation in benign and malignant thyroid tumors arising in a population exposed to low-dose external-beam irradiation in childhood
S Sadetzki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the TL10 promoter-592 C/C genotype
EC Breen et al.
CLINICAL IMMUNOLOGY (2003)
Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese chinese
MS Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
EM El-Omar et al.
GASTROENTEROLOGY (2003)
Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma
HD Shin et al.
HUMAN MOLECULAR GENETICS (2003)
Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma
LM Cunningham et al.
LEUKEMIA & LYMPHOMA (2003)
Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell carcinoma after renal transplantation
E Alamartine et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
分享论文
